Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, CancerCare Manitoba, Winnipeg, Canada.
Cell Res. 2010 Mar;20(3):314-31. doi: 10.1038/cr.2009.129. Epub 2009 Nov 24.
The complex formed by two members of the S100 calcium-binding protein family, S100A8/A9, exerts apoptosis-inducing activity in various cells of different origins. Here, we present evidence that the underlying molecular mechanisms involve both programmed cell death I (PCD I, apoptosis) and PCD II (autophagy)-like death. Treatment of cells with S100A8/A9 caused the increase of Beclin-1 expression as well as Atg12-Atg5 formation. S100A8/A9-induced cell death was partially inhibited by the specific PI3-kinase class III inhibitor, 3-methyladenine (3-MA), and by the vacuole H(+)-ATPase inhibitor, bafilomycin-A1 (Baf-A1). S100A8/A9 provoked the translocation of BNIP3, a BH3 only pro-apoptotic Bcl2 family member, to mitochondria. Consistent with this finding, DeltaTM-BNIP3 overexpression partially inhibited S100A8/A9-induced cell death, decreased reactive oxygen species (ROS) generation, and partially protected against the decrease in mitochondrial transmembrane potential in S100A8/A9-treated cells. In addition, either DeltaTM-BNIP3 overexpression or N-acetyl-L-cysteine co-treatment decreased lysosomal activation in cells treated with S100A8/A9. Our data indicate that S100A8/A9-promoted cell death occurs through the cross-talk of mitochondria and lysosomes via ROS and the process involves BNIP3.
由 S100 钙结合蛋白家族的两个成员 S100A8/A9 形成的复合物在不同来源的各种细胞中发挥诱导细胞凋亡的活性。在这里,我们提供的证据表明,潜在的分子机制涉及程序性细胞死亡 I(PCD I,凋亡)和 PCD II(自噬样死亡)。用 S100A8/A9 处理细胞会导致 Beclin-1 表达增加以及 Atg12-Atg5 形成。S100A8/A9 诱导的细胞死亡部分被特异性 PI3-激酶 III 抑制剂 3-甲基腺嘌呤(3-MA)和液泡 H(+)-ATP 酶抑制剂巴弗洛霉素 A1(Baf-A1)抑制。S100A8/A9 引发 BNIP3(一种仅具有 BH3 的促凋亡 Bcl2 家族成员)向线粒体易位。与此发现一致,DeltaTM-BNIP3 过表达部分抑制了 S100A8/A9 诱导的细胞死亡,减少了活性氧(ROS)的产生,并部分保护了 S100A8/A9 处理的细胞中线粒体跨膜电位的降低。此外,DeltaTM-BNIP3 过表达或 N-乙酰-L-半胱氨酸共同处理降低了 S100A8/A9 处理的细胞中溶酶体的激活。我们的数据表明,S100A8/A9 促进的细胞死亡是通过 ROS 介导的线粒体和溶酶体之间的串扰发生的,并且该过程涉及 BNIP3。